Skip to content

Investigation of the effects of an 8-week periodized creatine supplementation on muscle strength and mass as well as cognition in individuals over 50 years of age

Investigation of the effects of an 8-week periodized creatine supplementation on muscle strength and mass as well as cognition in individuals over 50 years of age

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039036
Enrollment
20
Registered
2026-01-21
Start date
2025-05-16
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigation of age-related changes in muscle strength, muscle mass, and physical and cognitive performance in healthy adults aged 50 years and older within a preventive exercise and supplementation study.

Interventions

Group 1: The intervention group will receive 5g of creatine daily for the first four weeks, followed by a placebo for the next four weeks. The supplements should be taken every morning after waking up

Sponsors

IST Hochschule für Management
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: All subjects should be at least 50 years old. They should not have any injuries or chronic illnesses that would be a contraindication for resistance training or creatine supplementation. In addition, they should not be taking any anabolic steroids or other medications that could influence resistance training or the effects of creatine.

Exclusion criteria

Exclusion criteria: Exclusion criteria: - Individuals who are unable to participate in the training at least twice per week. - Individuals taking medications that may affect creatine absorption or metabolism. - Individuals with liver diseases that could interfere with creatine metabolism. - Individuals with orthopedic or psychological conditions. - Individuals with organ diseases, in particular liver or kidney diseases, cardiovascular disorders, or a pacemaker, if these conditions contraindicate creatine supplementation.

Design outcomes

Primary

MeasureTime frame
Changes in muscle strength and body composition. Data will be collected before the intervention (baseline) and after eight weeks. Maximum strength will also be measured regularly during the intervention phase (every two weeks). Muscle strength: - One-repetition maximum on nine E-Gym machines - Handgrip strength measurement using a dynamometer - Chair rising test Body composition: - Bioimpedance analysis

Secondary

MeasureTime frame
Changes in mobility, quality of life, cardiovascular parameters, and cognitive performance. Data will be collected before the start of the intervention and after eight weeks. Mobility will be assessed using the Timed Up and Go test. Quality of life will be assessed using a standardized questionnaire. Blood pressure will be measured as a physiological parameter. Cognitive performance will be assessed using a Flanker/Stroop test.

Countries

Germany

Contacts

Public ContactTim Havers

IST Hochschule für Management

thavers@ist-hochschule.de+49 211 86668 6104

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026